Effect of vagotomy in Zollinger-Ellison syndrome

Charles T. Richardson, Mark Feldman, Robert N. McClelland, Richard M. Dickerman, Dean Kumpuris, John S. Fordtran

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

We evaluated the effect of vagotomy on gastric acid secretion and the clinical course in 3 patients with Zollinger-Ellison syndrome. Basal acid hypersecretion was reduced by 49, 86, and 96%, and peak acid output in response to pentagastrin was reduced by 36, 39, and 71% in the 3 patients. In one patient, 300 mg cimetidine reduced basal acid secretion from 65 to 20 meq/hr before vagotomy; whereas after vagotomy basal acid secretion was reduced from 36 to 0.6 meq/hr by the same dose of cimetidine. One patient has required no antisecretory therapy for 14 yr, whereas 2 patients have also been treated with cimetidine with excellent results. We conclude that vagotomy facilitates control of acid secretion in Zollinger-Ellison syndrome, and we recommend vagotomy and cimetidine rather than total gastrectomy or cimetidine alone for the management of these patients. This combined surgical and medical approach should also allow discovery and removal of isolated tumors in about 10% of patients.

Original languageEnglish (US)
Pages (from-to)682-686
Number of pages5
JournalGastroenterology
Volume77
Issue number4
StatePublished - Jan 1 1979

Fingerprint

Zollinger-Ellison Syndrome
Vagotomy
Cimetidine
Acids
Pentagastrin
Gastric Acid
Gastrectomy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Richardson, C. T., Feldman, M., McClelland, R. N., Dickerman, R. M., Kumpuris, D., & Fordtran, J. S. (1979). Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology, 77(4), 682-686.

Effect of vagotomy in Zollinger-Ellison syndrome. / Richardson, Charles T.; Feldman, Mark; McClelland, Robert N.; Dickerman, Richard M.; Kumpuris, Dean; Fordtran, John S.

In: Gastroenterology, Vol. 77, No. 4, 01.01.1979, p. 682-686.

Research output: Contribution to journalArticle

Richardson, CT, Feldman, M, McClelland, RN, Dickerman, RM, Kumpuris, D & Fordtran, JS 1979, 'Effect of vagotomy in Zollinger-Ellison syndrome', Gastroenterology, vol. 77, no. 4, pp. 682-686.
Richardson CT, Feldman M, McClelland RN, Dickerman RM, Kumpuris D, Fordtran JS. Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology. 1979 Jan 1;77(4):682-686.
Richardson, Charles T. ; Feldman, Mark ; McClelland, Robert N. ; Dickerman, Richard M. ; Kumpuris, Dean ; Fordtran, John S. / Effect of vagotomy in Zollinger-Ellison syndrome. In: Gastroenterology. 1979 ; Vol. 77, No. 4. pp. 682-686.
@article{fb94beb5a89f4c2d9a9b6d7e92f47d60,
title = "Effect of vagotomy in Zollinger-Ellison syndrome",
abstract = "We evaluated the effect of vagotomy on gastric acid secretion and the clinical course in 3 patients with Zollinger-Ellison syndrome. Basal acid hypersecretion was reduced by 49, 86, and 96{\%}, and peak acid output in response to pentagastrin was reduced by 36, 39, and 71{\%} in the 3 patients. In one patient, 300 mg cimetidine reduced basal acid secretion from 65 to 20 meq/hr before vagotomy; whereas after vagotomy basal acid secretion was reduced from 36 to 0.6 meq/hr by the same dose of cimetidine. One patient has required no antisecretory therapy for 14 yr, whereas 2 patients have also been treated with cimetidine with excellent results. We conclude that vagotomy facilitates control of acid secretion in Zollinger-Ellison syndrome, and we recommend vagotomy and cimetidine rather than total gastrectomy or cimetidine alone for the management of these patients. This combined surgical and medical approach should also allow discovery and removal of isolated tumors in about 10{\%} of patients.",
author = "Richardson, {Charles T.} and Mark Feldman and McClelland, {Robert N.} and Dickerman, {Richard M.} and Dean Kumpuris and Fordtran, {John S.}",
year = "1979",
month = "1",
day = "1",
language = "English (US)",
volume = "77",
pages = "682--686",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Effect of vagotomy in Zollinger-Ellison syndrome

AU - Richardson, Charles T.

AU - Feldman, Mark

AU - McClelland, Robert N.

AU - Dickerman, Richard M.

AU - Kumpuris, Dean

AU - Fordtran, John S.

PY - 1979/1/1

Y1 - 1979/1/1

N2 - We evaluated the effect of vagotomy on gastric acid secretion and the clinical course in 3 patients with Zollinger-Ellison syndrome. Basal acid hypersecretion was reduced by 49, 86, and 96%, and peak acid output in response to pentagastrin was reduced by 36, 39, and 71% in the 3 patients. In one patient, 300 mg cimetidine reduced basal acid secretion from 65 to 20 meq/hr before vagotomy; whereas after vagotomy basal acid secretion was reduced from 36 to 0.6 meq/hr by the same dose of cimetidine. One patient has required no antisecretory therapy for 14 yr, whereas 2 patients have also been treated with cimetidine with excellent results. We conclude that vagotomy facilitates control of acid secretion in Zollinger-Ellison syndrome, and we recommend vagotomy and cimetidine rather than total gastrectomy or cimetidine alone for the management of these patients. This combined surgical and medical approach should also allow discovery and removal of isolated tumors in about 10% of patients.

AB - We evaluated the effect of vagotomy on gastric acid secretion and the clinical course in 3 patients with Zollinger-Ellison syndrome. Basal acid hypersecretion was reduced by 49, 86, and 96%, and peak acid output in response to pentagastrin was reduced by 36, 39, and 71% in the 3 patients. In one patient, 300 mg cimetidine reduced basal acid secretion from 65 to 20 meq/hr before vagotomy; whereas after vagotomy basal acid secretion was reduced from 36 to 0.6 meq/hr by the same dose of cimetidine. One patient has required no antisecretory therapy for 14 yr, whereas 2 patients have also been treated with cimetidine with excellent results. We conclude that vagotomy facilitates control of acid secretion in Zollinger-Ellison syndrome, and we recommend vagotomy and cimetidine rather than total gastrectomy or cimetidine alone for the management of these patients. This combined surgical and medical approach should also allow discovery and removal of isolated tumors in about 10% of patients.

UR - http://www.scopus.com/inward/record.url?scp=0018296591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018296591&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 682

EP - 686

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -